Gregory S. Merrick
Papers
1
Total Citations
459
H-Index
1
About
Gregory S. Merrick is a leading figure in prostate cancer research, with a career focused on refining treatment outcomes and risk stratification for this disease. His primary research areas include radiation oncology, brachytherapy, and the comparative effectiveness of radical therapies for prostate cancer. Merrick’s most impactful contribution is his work with the Prostate Cancer Results Study Group, most notably the 2012 study "Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy," which has garnered over 459 citations. This seminal paper addressed a critical gap in the literature by systematically comparing treatment results using the most sensitive measurement tool—prostate-specific antigen (PSA) free survival. By synthesizing data across risk groups, Merrick provided clinicians with a clearer, evidence-based framework for selecting optimal therapies, from surgery to radiation. His work has been instrumental in standardizing outcome reporting and improving patient counseling. Beyond this study, Merrick has authored numerous papers on brachytherapy techniques and long-term survivorship, cementing his reputation as a meticulous researcher whose findings directly shape clinical practice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1